Electrochemical Cytosensor with Dual-Site Recognition Fabricated by In Situ Catalase-Encapsulated Metal–Organic Frameworks for Isolation and Detection of Circulating Tumor Cells in Whole Blood
ACS Sensors · 2026
DOI: 10.1021/acssensors.6c01378 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Na Gan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Study, Chengdu University, Chengdu610106, China. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Catalase, Metal-Organic Frameworks, Electrochemical Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Circulating tumor cells (CTCs) are critical biomarkers for cancer prognosis and treatment monitoring, yet their detection remains challenging due to low abundance and phenotypic heterogeneity. Herein, we developed a dual-aptamer-conjugated electrochemical cytosensor using an in situ catalase (CAT)-encapsulated nanozyme CAT@Fe(SS)MOF-EpCAM/MUC1 (CMA) with a core-shell structure (64.8% catalase encapsulation efficiency) and magnetic nanoparticles Fe3O4-EpCAM/MUC1 (FA) for highly specific CTC capture. The CMA probe achieved 85.5% aptamer grafting efficiency and exhibited enhanced peroxidase (POD)-like activity through CAT-Fe(SS)MOF synergistic catalysis, significantly amplifying the differential pulse voltammetry (DPV) signal. The cytosensor achieved a detection limit of 2 cells/mL in 1 mL of whole blood, taking 95 min, with a wide linear range from 2 to 40 cells/mL. It demonstrated high specificity toward dual-antigen-expressing CTCs and showed promising clinical utility in discriminating lung cancer patients from healthy donors. The system demonstrated good anticoagulant properties, hemolysis rates of <5%, and IC50 values of 558 μg/mL (CMA) and >700 μg/mL (FA) for RAW264.7. This novel electrochemical cytosensor offers a portable and efficient platform for CTCs detection, thereby paving the way for its meaningful integration into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Advanced Study, Chengdu University, Chengdu610106, China.
- School of Food and Biological Engineering, Chengdu University, Chengdu610106, China.
- Department of Laboratory Medicine, West China Hospital, Sichuan Clinical Research Center for Laboratory Medicine, Clinical Laboratory Medicine Research Center of West China Hospital, Sichuan University, Chengdu610041, C…
- Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen518055, China.
ORCID-Profile: Tingting Zeng, Di Wu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Gan, N., Liu, P., Zeng, T., Chen, S., Mo, Y., Zhong, J., Song, Y., Chen, Y., & Wu, D. (2026). Electrochemical Cytosensor with Dual-Site Recognition Fabricated by In Situ Catalase-Encapsulated Metal–Organic Frameworks for Isolation and Detection of Circulating Tumor Cells in Whole Blood. ACS Sensors. https://doi.org/10.1021/acssensors.6c01378
Vancouver
Gan N, Liu P, Zeng T, Chen S, Mo Y, Zhong J, et al. Electrochemical Cytosensor with Dual-Site Recognition Fabricated by In Situ Catalase-Encapsulated Metal–Organic Frameworks for Isolation and Detection of Circulating Tumor Cells in Whole Blood. ACS Sensors. 2026. doi:10.1021/acssensors.6c01378
BibTeX
@article{Gan2026,
author = {Gan, Na and Liu, Peiran and Zeng, Tingting and Chen, Si and Mo, Yazhi and Zhong, Jie and Song, Yali and Chen, Yuemei and Wu, Di},
title = {Electrochemical Cytosensor with Dual-Site Recognition Fabricated by In Situ Catalase-Encapsulated Metal–Organic Frameworks for Isolation and Detection of Circulating Tumor Cells in Whole Blood},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.6c01378}
}
EUVIMED